Fangda represented Kyowa Kirin on the deal. Kyowa Kirin, a global leading R&D company for innovative drugs, has reached a series of asset restructuring arrangements with...
Kyowa Kirin’s Asset Restructuring Arrangements with Winhealth
Grünenthal’s Joint Venture Collaboration With Kyowa Kirin International
Freshfields Bruckhaus Deringer advised Grünenthal. Allen & Overy advised Kyowa Kirin International. Grünenthal, the Germany-based global leader in pain management and related diseases, on a collaboration...